Reperfusion Injury Clinical Trial
Official title:
Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors - a Prospective Cohort Study
Verified date | April 2020 |
Source | University Hospital, Aachen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Kidney transplantation (KT) has emerged as the mainstay of treatment for end-stage kidney disease. In an effort to address the widening gap between demand and supply of donor organs, there has been an increase in the numbers of "marginal" or functionally impaired renal allografts that had to be accepted for KT over the decades. The use of extended criteria donor (ECD) allografts is associated with a higher incidence of primary graft non-function (PNF) and/or delayed graft function (DGF). Hypothermic oxygenated machine perfusion (HOPE) has been successfully tested in pre-clinical experiments and in a few clinical series of donation after cardiac death (DCD) in liver transplantation. The present trial is an investigator-initiated pilot study on the effects of HOPE on ECD-allografts in donation after brain death (DBD) KT. Fifteen kidney allografts will be submitted to 2 hours of HOPE before implantation and are going to be compared to a case matched group transplanted after conventional cold storage (CCS).
Status | Completed |
Enrollment | 45 |
Est. completion date | March 30, 2020 |
Est. primary completion date | September 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: Dialysis-requiring Patients, suffering from end stage kidney disease, listed for KT and receiving ECD organs at the Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Informed consent is obtained from all subjects participating in the trial by a qualified member of the study team. ECD is defined as followed: deceased donors > 60 years and older, and those aged between 50-59 years with at least two of the following conditions: cerebrovascular cause of death, serum Creatinine greater than 1.5 mg/dL (132.6 µmol/L), history of arterial hypertension Exclusion Criteria: 1. Recipients of living donor kidney transplants 2. Previous kidney transplantation 3. Participation in other kidney related trials 4. The subject received an investigational drug within 30 days prior to inclusion 5. The subject is unwilling or unable to follow the procedures outlined in the protocol 6. The subject is mentally or legally incapacitated 7. Non-German or non-English speakers 8. Family members of the investigators or employees of the participating department 9. The subject is mentally or legally incapacitated 10. The subject suffers from uncontrolled bacterial or viral infection |
Country | Name | City | State |
---|---|---|---|
Germany | Department of Surgery and Transplantation, University Hospital RWTH Aachen | Aachen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Aachen |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DGF | DGF (defined as the need for dialysis in the first 7-days post-transplantation) | 7 days post-transplant | |
Secondary | CRR2, CRR5 | Creatinine reduction ratio day 2 (CRR2= creatinine day 1-creatinine day 2/creatinine day 1) and CRR5 (CRR5=pre-transplant creatinine-creatinine day 5/pre-transplant creatinine) | 5 days post-transplant | |
Secondary | postoperative complications | Clavien-Dindo complication score | Subjects will be followed 6 months postoperatively | |
Secondary | Cumulative postoperative complications | Comprehensive complication index (CCI) | Subjects will be followed 6 months postoperatively | |
Secondary | Duration of intensive care stay | Duration of ICU stay | Subjects will be followed 6 months postoperatively | |
Secondary | Duration of hospital stay | Duration of hospitalisation | Subjects will be followed 6 months postoperatively | |
Secondary | Graft survival | Six months graft survival | Subjects will be followed 6 months postoperatively | |
Secondary | Renal function | Renal function (serum creatinine and estimated glomerular filtration rate (eGFR)) | Subjects will be followed 6 months postoperatively | |
Secondary | Perfusion Parameter | Flow and thus renal resistance | During HOPE |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02251041 -
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
|
Phase 2 | |
Completed |
NCT01944605 -
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
|
N/A | |
Completed |
NCT00529607 -
Diagnostics for the Reperfusion Injury Following MI
|
N/A | |
Completed |
NCT00778323 -
Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT00994981 -
Magnesium Administration in Liver Transplantation and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT02731651 -
Effect of Pneumoperitoneum on Human Ovary
|
N/A | |
Completed |
NCT02286544 -
Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00189007 -
Antenatal Allopurinol During Fetal Hypoxia
|
Phase 3 | |
Completed |
NCT01167569 -
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
|
Phase 4 | |
Completed |
NCT00246740 -
Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
|
Phase 2 | |
Enrolling by invitation |
NCT05725694 -
Acute Ischaemic STROKE: From LAboratory to the Patient's BED
|
||
Completed |
NCT00402506 -
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
|
Phase 3 | |
Completed |
NCT03176823 -
Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury
|
N/A | |
Completed |
NCT02512640 -
Comparison of Oxidative Stress Changes in Different Ventilation Strategies During Gynecologic Laparoscopic Surgery
|
N/A | |
Recruiting |
NCT05574296 -
Hydrogen's Feasibility and Safety as a Therapy in ECPR
|
Phase 1 | |
Active, not recruiting |
NCT02127996 -
GLP-1 Loading During Elective Percutaneous Coronary Intervention
|
Phase 2 | |
Suspended |
NCT02850471 -
Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery
|
Phase 1/Phase 2 | |
Terminated |
NCT02394405 -
Myocardial and Renal Dysfunction by Oxidative Stress Caused by Cardiac Surgery
|
||
Completed |
NCT00516711 -
Role of Volatile Anesthetics for Hepatic Protection
|
N/A | |
Terminated |
NCT04316468 -
Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
|